Indicated for: malaria
Route of administration: oral
Substance: mefloquine (antimalarial)
ATC: P01BC02 (Antiparasitic products, insecticides and repellents | Antimalarials | Methanolquinolines)
Mefloquine is a medication used for the prevention and treatment of malaria. It is effective against several Plasmodium species, including Plasmodium falciparum, which is responsible for severe forms of malaria.
This medication is taken orally, usually once a week for prophylaxis or according to a specific regimen for treatment. It is important to start taking it at least one week before traveling to an endemic area and to continue for several weeks after returning.
Mefloquine may cause side effects such as nausea, dizziness, or sleep disturbances. In rare cases, neuropsychiatric reactions such as anxiety or depression may occur. Patients with a history of psychiatric disorders should avoid using this medication.
To ensure effectiveness, it is essential to follow the dosing schedule and consult a doctor before use, especially if taking other medications.
NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment
Price
Copayment
Patient
392.68 RON
392.68 RON
0.00 RON